David Zaccardelli insider trades
Open-market stock purchases and sales by David Zaccardelli, Unknown at SAB Biotherapeutics, Inc, from SEC Form 4 filings since Jan 2, 2015.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 5, 2026 | SABS SAB Biotherapeutics, Inc | Bought (not open market) | — |
| Oct 7, 2025 | VRNA Verona Pharma plc | Sold (not open market) | — |
| Oct 7, 2025 | VRNA Verona Pharma plc | Bought (not open market) | — |
| Oct 7, 2025 | VRNA Verona Pharma plc | Sold (not open market) | — |
| Oct 7, 2025 | VRNA Verona Pharma plc | Bought (not open market) | — |
| Oct 7, 2025 | VRNA Verona Pharma plc | Bought (not open market) | — |
| Oct 7, 2025 | VRNA Verona Pharma plc | Bought (not open market) | — |
| Oct 7, 2025 | VRNA Verona Pharma plc | Bought (not open market) | — |
| Oct 7, 2025 | VRNA Verona Pharma plc | Bought (not open market) | — |
Companies traded
- SABS SAB Biotherapeutics, Inc: other filings, last Jan 5, 2026
- VRNA Verona Pharma plc: 48 sales, last Oct 7, 2025
- DOVA Dova Pharmaceuticals Inc: 1 buy, 3 sales, last Nov 12, 2019
- MLNT Melinta Therapeutics, Inc /new/: 1 buy, last Jun 11, 2019
- CEMP Cempra, Inc: other filings, last Dec 9, 2016
- UTHR UNITED THERAPEUTICS Corp: 19 sales, last May 13, 2016